Wave Life Sciences

WAVE Life Sciences Ltd (WVE) Q3 2024: Everything You Need to Know Ahead of Earnings
WAVE Life Sciences Ltd (NASDAQ:WVE) is set to release its Q3 2024 earnings on Nov 12, 2024. The consensus estimate for Q3 2024 revenue is $16.95 million, and the earnings are expected to come in at -$0.
Wave Life Sciences’ Q3 2024 Advances in RNA Therapies
Wave Life Sciences Pte. Ltd ( (WVE) ) has released its Q3 earnings. Here is a breakdown of the information Wave Life Sciences Pte. Ltd
Wave Life Sciences: Q3 Earnings Snapshot
Wave Life Sciences Pte. Ltd. (WVE) on Tuesday reported a loss of $61.8 million in its third quarter. On a per-share basis, the Singapore-based company said it had a loss of 47 cents. The results did not meet Wall Street expectations.
Wave Life Sciences (WVE) Reports Q3 Loss, Lags Revenue Estimates
Wave Life Sciences (WVE) came out with a quarterly loss of $0.47 per share versus the Zacks Consensus Estimate of a loss of $0.28. This compares to earnings of $0.07 per share a year ago. These figures are adjusted for non-recurring items. This quarterly ...
Wave Life Sciences reports Q3 EPS (47c), consensus (28c)
Reports Q3 revenue ($7.676M), consensus $16.95M. Published first on TheFly – the ultimate source for real-time, market-moving breaking
Wave Life Sciences Reports Third Quarter 2024 Financial Results and Provides Business Update
Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, today announced financial results for the third quarter ended September 30,
Wave Life Sciences Gains Buy Rating from Andrew Fein Amid Promising Trial Advancements and Potential Accelerated Approval Pathways
Wave Life Sciences (WVE – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Andrew ...
Hosted on MSN10h
Wave Life Sciences Ltd. (NASDAQ:WVE) Q3 2024 Earnings Call Transcript
Wave Life Sciences Ltd. (NASDAQ:WVE) Q3 2024 Earnings Call Transcript November 12, 2024 Operator: Good morning, and ...
MarketBeat on MSN26d
Wave Life Sciences Rockets 70% on Historic RNA Editing Success
For the most recent quarter, Wave Life Sciences reported -$0.25 earnings per share (EPS), missing the consensus ...
Business Insider6h
Wave Life Sciences: Buy Rating Affirmed on Promising RNA Programs and Strong Regulatory Pathway
Wells Fargo analyst Tiago Fauth maintained a Buy rating on Wave Life Sciences (WVE – Research Report) yesterday and set a price target of $22.00. Tiago Fauth has given his Buy rating due to a ...
ETF Daily News27d
Wave Life Sciences (NASDAQ:WVE) PT Raised to $22.00
Wave Life Sciences (NASDAQ:WVE – Get Free Report) had its price objective upped by Leerink Partners from $20.00 to $22.00 in a note issued to investors on Wednesday, Benzinga reports.
Morningstar2d
WAVE Life Sciences Ltd
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Wave Life Sciences Ltd. (WVE) Q3 2024 Earnings Call Transcript
Good morning, and welcome to the Wave Life Sciences Third Quarter 2024 Financial Results Conference Call. At this time, all participants are in a listen only mode. As a reminder, this call is being ...
BioSpace2d
After Decades of Failure, First Disease-Modifying Huntington’s Treatment on the Horizon
The past four years have brought disappointment for the Huntington’s community, but optimism is growing as companies ...